- Home
- SKT vs LIVN Comparison
SKT vs LIVN Comparison
Compare SKT & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SKT | LIVN |
|---|---|---|
| Founded | 1981 | 1987 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.5B |
| IPO Year | 1993 | 1993 |
Fundamental Metrics
Financial Performance| Metric | SKT | LIVN |
|---|---|---|
| Price | $34.11 | $65.69 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 8 |
| Target Price | $36.17 | ★ $67.38 |
| AVG Volume (30 Days) | ★ 1.2M | 632.5K |
| Earning Date | 02-24-2026 | 02-25-2026 |
| Dividend Yield | ★ 3.46% | N/A |
| EPS Growth | ★ 8.00 | N/A |
| EPS | ★ 0.94 | N/A |
| Revenue | $575,140,000.00 | ★ $1,348,962,000.00 |
| Revenue This Year | $3.44 | $12.25 |
| Revenue Next Year | $4.54 | $6.68 |
| P/E Ratio | $35.99 | ★ N/A |
| Revenue Growth | ★ 10.01 | 8.63 |
| 52 Week Low | $28.69 | $32.48 |
| 52 Week High | $36.76 | $67.92 |
Technical Indicators
Market Signals| Indicator | SKT | LIVN |
|---|---|---|
| Relative Strength Index (RSI) | 55.04 | 53.24 |
| Support Level | $33.25 | $62.91 |
| Resistance Level | $34.50 | $66.94 |
| Average True Range (ATR) | 0.75 | 2.14 |
| MACD | 0.16 | -0.11 |
| Stochastic Oscillator | 76.85 | 47.01 |
Price Performance
Historical ComparisonAbout SKT Tanger Inc.
Tanger Inc is an owners and operators of outlet and open-air centers in the United States and Canada. It is a fully-integrated, self-administered and self-managed REIT, which focuses on developing, acquiring, owning, operating and managing outlet and open-air shopping centers. Its consolidated portfolio consisted of 31 outlet centers and 2 open-air lifestyle centers, with a total gross leasable area of approximately 13.0 million square feet.
About LIVN LivaNova PLC
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.